Publications Office of the EU
VERTEX - CHESTIC FIBROSIS DRUGS - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

VERTEX - CHESTIC FIBROSIS DRUGS Text automatically translated in your browsing language Automatically translated

  • Awarded
    25/03/2025
  • Today
    20/04/2025
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
CONSORCIO CORPORACIƓ SANITƀRIA PARC TAULI SABADELL
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: ES511 Barcelona
Business sector (Main CPV)
33670000 Medicinal products for the respiratory system
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
701,539.06 EUR
Tender reference number
25EX30281-1
Description

VERTEX - CHESTIC FIBROSIS DRUGS FOR CCSPT Text automatically translated in your browsing language Automatically translated

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
Award method
Criterion:
Type: cost
Description: Oferta
Weight (percentage, exact): 100
Estimated value
Not available
Final contracted value
701,539.06 EUR
Award of contract
Official name: Vertex Pharmaceuticals Spain, S.L
Postal address:
Town: ValĆØncia
Postal code: 46009
Country:
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.